Showing results (681-690 of 729) with videos related to
Sort By:
Pageof 73
Journal of Gastroenterology|April 23, 1999
Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, JapanK Omagari, H Kinoshita, Y Kato, et al.Clinical and Experimental Immunology|March 1, 1996
Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB)J Kadota, Y Matsubara, Y Ishimatsu, et al.The Journal of Hospital Infection|May 3, 2006
Endoscope disinfection using chlorine dioxide in an automated washer-disinfectorH Isomoto, M Urata, K Kawazoe, et al.European Journal of Cancer (Oxford, England : 1990)|September 3, 2002
Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancerT Kasai, M Oka, H Soda, et al.Alimentary Pharmacology & Therapeutics|July 10, 2003
High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infectionH Isomoto, K Inoue, H Furusu, et al.Antimicrobial Agents and Chemotherapy|May 19, 2000
Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cellsK Terashi, M Oka, H Soda, et al.Internal Medicine (Tokyo, Japan)|February 24, 2001
Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis GroupK Omagari, J Masuda, Y Kato, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I study of irinotecan combined with carboplatin in previously untreated solid cancersM Fukuda, M Oka, H Soda, et al.Respiratory Medicine|January 28, 2005
High plasma concentrations of osteopontin in patients with interstitial pneumoniaJ Kadota, S Mizunoe, K Mito, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|April 1, 1997
[Efficacy of erythromycin inhalation in chronic respiratory infection caused by Pseudomonas aeruginosa]K Yanagihara, K Tomono, T Sawai, et al.Pageof 73